Oditrasertib
Oditasertib (DNL-788) is a potent and selective RIPK1 inhibitor (IC50 < 100 nM) . It is a research tool for investigating RIPK1-driven pathologies, with applications in preclinical studies of neurological and inflammatory diseases, including multiple sclerosis and Alzheimer's disease.
Product Specifications
CAS Number
2252271-93-3
Product Name Alternative
ADA 07, ADA-07, DNL-788, Oditrasertib, RIP kinase, RIPK1, RIPkinase
Field of Research
Cell Biology, Signal Transduction
Purity
98.00% (May vary between batches)
Solubility
DMSO:80 mg/mL (270.93 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (11.18 mM)
Smiles
N#CC1=CN=CC2=C1OCCN (C (=O) C (C) (C) C (F) F) C2
Molecular Formula
C14H15F2N3O2
Molecular Weight
295.28
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AHE26002 100 μg
Recombinant Human THPO Protein, N-His & C-His (Active)
Sign In for Pricing
View Details NBP2-12410AF647 0.1 mL
Rat Monoclonal Granzyme G Antibody (RM0247-12f21) [Alexa Fluor 647]
Sign In for Pricing
View Details 
GTR15384634 1 Vial
Lentiviral human GBE1 sgRNA gene knockout kit - Lentiviral human GBE1 sgRNA gene knockout kit (100)
Sign In for Pricing
View Details